Asheville, NC, United States of America

George Doellgast



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of George Doellgast

Introduction

George Doellgast is an accomplished inventor based in Asheville, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of three patents to his name, Doellgast's work has the potential to impact pharmaceutical compositions and medicaments.

Latest Patents

One of his latest patents involves carrier immunoglobulins. This patent discloses an isolated antigen binding protein, which can include antibodies or antibody fragments. The patent also details pharmaceutical compositions and medicaments that comprise the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments, the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide.

Career Highlights

George Doellgast is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions in the field of immunology and drug development.

Collaborations

Some of his notable coworkers include Kenneth William Walker and Yue-Sheng Li, who contribute to the collaborative efforts in their research projects.

Conclusion

George Doellgast's innovative work in the field of biotechnology, particularly with antigen binding proteins, showcases his commitment to advancing medical science. His contributions through patents and collaborations highlight the importance of teamwork in achieving groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…